These results suggested that anti-HBx could reduce the hepatocarcinogenesis associated with HBx-induced BNIP3L-dependent mitophagy and glycolysis metabolism reprogramming in HCC cells. This evidence concerns the gene BNIP3L and hepatocellular carcinoma.